| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| N-acetylneuraminic acid phosphatase (NANP) from ORIGENE TECHNOLOGIES | LY407388 | 100 ug | ORIGENE TECHNOLOGIES |
| N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (NAGPA) from ORIGENE TECHNOLOGIES | LY414096 | 100 ug | ORIGENE TECHNOLOGIES |
| SEMA6C - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417534 | 1 kit | ORIGENE TECHNOLOGIES |
| N-acetylneuraminic acid synthase (NANS) from ORIGENE TECHNOLOGIES | LY412808 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema3c - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515495 | 1 kit | ORIGENE TECHNOLOGIES |
| Sema4c - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515502 | 1 kit | ORIGENE TECHNOLOGIES |
| Sema6c - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515510 | 1 kit | ORIGENE TECHNOLOGIES |
| SEMA6D - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414172 | 1 kit | ORIGENE TECHNOLOGIES |
| SEMA4D - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408521 | 1 kit | ORIGENE TECHNOLOGIES |
| Sema3d - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515496 | 1 kit | ORIGENE TECHNOLOGIES |
| SEMA3D - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN416032 | 1 kit | ORIGENE TECHNOLOGIES |
| Sema4d - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515503 | 1 kit | ORIGENE TECHNOLOGIES |
| Sema6d - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515511 | 1 kit | ORIGENE TECHNOLOGIES |
| SEMA4D Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH308521 | 10 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A (SEMA3A) from ORIGENE TECHNOLOGIES | LY416877 | 100 ug | ORIGENE TECHNOLOGIES |
| SEMA3D Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH316032 | 10 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B (SEMA3B), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417853 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B (SEMA3B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423670 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C (SEMA3C) from ORIGENE TECHNOLOGIES | LY401916 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D (SEMA3D) from ORIGENE TECHNOLOGIES | LY407304 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E (SEMA3E) from ORIGENE TECHNOLOGIES | LY415758 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F (SEMA3F) from ORIGENE TECHNOLOGIES | LY418156 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G (SEMA3G) from ORIGENE TECHNOLOGIES | LY412627 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A (SEMA4A) from ORIGENE TECHNOLOGIES | LY402923 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A (SEMA4A), transcript variant 4 from ORIGENE TECHNOLOGIES | LY434343 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B (SEMA4B), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412595 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B (SEMA4B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404648 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C (SEMA4C) from ORIGENE TECHNOLOGIES | LY402615 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D (SEMA4D), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416686 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F (SEMA4F) from ORIGENE TECHNOLOGIES | LY418105 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G (SEMA4G) from ORIGENE TECHNOLOGIES | LY413475 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A (SEMA5A) from ORIGENE TECHNOLOGIES | LY418314 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B (SEMA5B), transcript variant 1 from ORIGENE TECHNOLOGIES | LY422156 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A (SEMA6A) from ORIGENE TECHNOLOGIES | LY412307 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B (SEMA6B) from ORIGENE TECHNOLOGIES | LY410389 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C (SEMA6C), transcript variant 1 from ORIGENE TECHNOLOGIES | LY433594 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D (SEMA6D), transcript variant 4 from ORIGENE TECHNOLOGIES | LY406989 | 100 ug | ORIGENE TECHNOLOGIES |
| Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D (SEMA6D), transcript variant 6 from ORIGENE TECHNOLOGIES | LY410960 | 100 ug | ORIGENE TECHNOLOGIES |
| SEMA3E - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN416038 | 1 kit | ORIGENE TECHNOLOGIES |
| Sema3e - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515497 | 1 kit | ORIGENE TECHNOLOGIES |
| SEMA4F - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406544 | 1 kit | ORIGENE TECHNOLOGIES |
| SEMA3F - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408333 | 1 kit | ORIGENE TECHNOLOGIES |
| Sema3f - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515498 | 1 kit | ORIGENE TECHNOLOGIES |
| Sema4f - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515504 | 1 kit | ORIGENE TECHNOLOGIES |
| SEMA4F Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH306544 | 10 ug | ORIGENE TECHNOLOGIES |
| SEMA4G - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410343 | 1 kit | ORIGENE TECHNOLOGIES |
| SEMA3G - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN422035 | 1 kit | ORIGENE TECHNOLOGIES |
| Sema3g - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515499 | 1 kit | ORIGENE TECHNOLOGIES |
| Sema4g - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515505 | 1 kit | ORIGENE TECHNOLOGIES |
| Semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) (SEMA7A), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401196 | 100 ug | ORIGENE TECHNOLOGIES |